A New Method for Preparation of Monomeric Destetrapeptide Human Insulin

Yi-Cheng Wang,Jia-Hao Shi,Yuan-Xing Zhang,Jian Fei
DOI: https://doi.org/10.3969/j.issn.1674-7666.2007.05.029
2007-01-01
Abstract:Monomeric destetrapeptide human insulin (DTI, human insulin with B27-30 removed) was obtained from a monomeric insulin precursor (MIP) expressed in Picha pastoris through two step subsequent hydrolysis with trypsin and carboxypeptidase B. The crude MIP which purified by hydrophobic and size-exclusion chromatography was converted to be DTI by hydrolysis with trypsin for 3 h and with carboxypeptidase B for 6 h. Before hydrolysis with carboxypeptidase B, the activity of trypsin was inhibited by adding inhibitor p-aminobenzamidine for 15 min. The crude DTI was then purified by reverse processing chromatography. The yield of MIP was 150 mg per liter of culture, and the overall yield of purified DTI from crude MIP was 77%. The in vivo biological activity of DTI as determined by the mouse convulsion assay was 22 IU/mg. Compared with native insulin, DTI molecules do not aggregate in solution but exist in the monomeric form.
What problem does this paper attempt to address?